Nu Skin Enterprises Inc

Nu Skin Enterprises reported second-quarter 2026 adjusted earnings of 20 cents per share, matching the Zacks Consensus Estimate but down 53.5% from 43 cents a year earlier. Quarterly revenues fell 17.1% to $320.1 million, missing the $345 million consensus, with Rhyz revenues dropping 25% to $48.9 million. The company cut its full-year 2026 revenue guidance to a range of $1.28 billion to $1.35 billion from the prior $1.35 billion to $1.50 billion, and lowered its adjusted EPS outlook to 70 to 90 cents from 80 cents to $1.20. For the third quarter, Nu Skin expects revenues of $310 million to $340 million and adjusted earnings of 10 to 20 cents per share.

Zacks Equity Research has identified The Estee Lauder Companies, e.l.f. Beauty, Helen of Troy, and Nu Skin Enterprises as cosmetics stocks worth watching, citing favorable industry trends. The Zacks Cosmetics industry is benefiting from sustained demand for skincare, makeup, fragrance, and personal care products, driven by consumers' focus on self-care and wellness. Innovation in science-backed formulations and clean beauty, along with digital engagement tools, is fueling growth, though companies face cautious spending, elevated input costs, and supply-chain uncertainties. The industry carries a Zacks Industry Rank of 107, placing it in the top 43% of over 247 industries, and its consensus earnings estimate for the current fiscal year has risen 17% since early April 2026. Estee Lauder, rated Zacks Rank #2, has a consensus EPS estimate of $2.41 and its stock gained 17.1% over the past year; Helen of Troy, also Rank #2, has an EPS estimate of $3.44 and an 8.4% gain; Nu Skin, Rank #3, has an EPS estimate of $1.00 and a 35% decline; and e.l.f. Beauty, Rank #3, saw its EPS estimate drop 8.6% to $3.30 and its stock fall 46.7%.